Tag Archives: biotech regulatory issues

2011 BIO International event spotlights expert feedback on regulatory strategy

Our good friend John Carroll, blogs on the free ranging discussion he will be hosting during the 2011 BIO International Convention, and tackling one of the most complex issues of the day for biopharma companies. You can send your questions to the panel of experts discussing the issues. In the meantime, you can also email John if there are any regulatory issues you are interested on discussing.

Events, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,